Home › Compare › PHMMF vs MCD

PHMMF vs MCD: Dividend Comparison 2026

PHMMF yields 0.97% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHMMF wins by $60.0K in total portfolio value
10 years
PHMMF
PHMMF
● Live price
0.97%
Share price
$96.00
Annual div
$0.93
5Y div CAGR
68.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$138.5K
Annual income
$65,086.57
Full PHMMF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — PHMMF vs MCD

📍 PHMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHMMFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHMMF + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PHMMF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHMMF
Annual income on $10K today (after 15% tax)
$82.26/yr
After 10yr DRIP, annual income (after tax)
$55,323.58/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, PHMMF beats the other by $33,030.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHMMF + MCD for your $10,000?

PHMMF: 50%MCD: 50%
100% MCD50/50100% PHMMF
Portfolio after 10yr
$108.5K
Annual income
$45,657.13/yr
Blended yield
42.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

PHMMF
No analyst data
Altman Z
8.3
Piotroski
6/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHMMF buys
0
MCD buys
0
No recent congressional trades found for PHMMF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHMMFMCD
Forward yield0.97%2.35% ✓
Annual dividend / share$0.93$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR68.1% ✓42.3%
Portfolio after 10y$138.5K ✓$78.5K
Annual income after 10y$65,086.57 ✓$26,227.70
Total dividends collected$111.9K ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: PHMMF vs MCD ($10,000, DRIP)

YearPHMMF PortfolioPHMMF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$10,863$162.67$10,815$334.85+$48.00 → PHMMF
2$11,901$277.61$11,826$491.71+$75.00 → PHMMF
3$13,212$477.81$13,123$730.06+$89.00 → PHMMF
4$14,970$833.33$14,853$1,100.07+$117.00 → PHMMF
5$17,501$1,483.41$17,257$1,690.61+$244.00 → PHMMF
6$21,451$2,724.54$20,752$2,667.01+$699.00 → PHMMF
7$28,198$5,246.31$26,103$4,354.83+$2.1K → PHMMF
8$41,007$10,834.88$34,794$7,437.78+$6.2K → PHMMF
9$68,632$24,753.88$49,926$13,461.60+$18.7K → PHMMF
10$138,522$65,086.57$78,550$26,227.70+$60.0K → PHMMF

PHMMF vs MCD: Complete Analysis 2026

PHMMF — Stock

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.

Full PHMMF Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this PHMMF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHMMF vs SCHDPHMMF vs JEPIPHMMF vs OPHMMF vs KOPHMMF vs MAINPHMMF vs YUMPHMMF vs QSRPHMMF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.